The World Anti-Doping Agency (WADA) announces that, in accordance with the , Sir Craig Reedie, Chairman of WADA’s Executive Committee (ExCo), has approved lifting the partial suspension of the accreditation of the Doping Control Laboratory at the Karolinska University Hospital (Stockholm Laboratory) as it relates to the gas chromatography / combustion / isotope ratio mass spectrometry (GC/C/IRMS) method.
The Stockholm Laboratory, which had its accreditation partially suspended for the GC/C/IRMS method on , has resolved the issue that led to the partial suspension. As such, on 29 July 2019, the WADA Laboratory Expert Group recommended to the Agency’s ExCo Chairman that the partial suspension be lifted. Therefore, effective 1 August 2019, the Stockholm Laboratory, which had continued to carry out all of its other regular anti-doping activities, is no longer required to securely transport samples that require GC/C/IRMS analysis to another WADA-accredited laboratory.
“WADA is pleased to confirm that the Stockholm Laboratory’s accreditation has been reinstated twelve months after the Laboratory was partially suspended,” said WADA Director General, Olivier Niggli. “We commend the Stockholm Laboratory for their comprehensive response in addressing the issue that led to the partial suspension; and, assure athletes that they can be confident that the Laboratory is operating at the high standards required by WADA and the global anti-doping program.”
WADA is responsible for accrediting and re-accrediting anti-doping laboratories, thereby ensuring that they maintain the highest quality standards. When a laboratory does not meet ISL requirements, WADA may decide to suspend or revoke the laboratory’s accreditation. This monitoring role is conducted in conjunction with ISO/IEC 17025 assessment by independent national accreditation bodies that are full members of the International Laboratory Accreditation Cooperation (ILAC).
The full list of accredited laboratories can be found on .